BOSTON BIO SYSTEMS LTD. Complete Financial Statements

In FYNone, BOSTON BIO SYSTEMS LTD. (BOSTONBIO) reported revenue ₹1 Cr, net profit ₹-1 Cr and EPS ₹-0.60 and ROE of -16.7%. Full financial statements from FY2015 to FY2025 (8 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see BOSTONBIO share price.

8 Years of Data
2025 - 2015

Complete Financial Data Export

Profitability Ratios

Operating Margin -284.00% 2025 data
Return on Assets -6.67% 2025 data
Return on Equity -16.67% 2025 data

Balance Sheet Ratios

Current Ratio 1.80 2025 data
Debt to Equity 2.50 2025 data
Equity Ratio 40.00% 2025 data

BOSTONBIO Revenue, Net Profit & EBITDA — Year-on-Year Growth

BOSTONBIO YoY (March 2025 vs Period), EBITDA +100.0%.

EBITDA Growth
+100.0%
Year-over-Year
Assets Growth
+36.4%
Year-over-Year
Equity Growth
-14.3%
Year-over-Year
Liabilities Growth
+36.4%
Year-over-Year

BOSTONBIO Income Statement — Revenue, EBITDA & Net Profit

BOSTON BIO SYSTEMS LTD. revenue ₹1 Cr, EBITDA ₹0 Cr, net profit ₹-1 Cr, EPS ₹-0.60 (None). Explore BOSTONBIO investment value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2018 March 2017 March 2016 March 2015
Revenue 1 0 0 0 0 1 1 2 0
Expenses 1 1 0 0 0 1 1 2 0
EBITDA 0 -1 0 0 0 0 0 0 0
Operating Profit Margin % -33.00% -284.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.00%
Depreciation 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 -1 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0
Net Profit -1 -1 0 0 0 0 0 0 0
Earnings Per Share (₹) -0.60 -0.78 -0.20 0.00 0.00 0.00 0.00 0.00 0.00

BOSTONBIO Balance Sheet — Assets, Liabilities & Shareholders' Equity

BOSTONBIO total assets ₹15 Cr, total equity ₹6 Cr, total liabilities ₹15 Cr (2025) — ROE -16.7%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2018 2017 2016 2015
ASSETS
Total Assets 15 11 11 11 10 9 9 7
Current Assets 9 5 5 5 4 4 3 1
Fixed Assets 0 0 0 0 0 0 0 0
Capital Work in Progress 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0
Other Assets 15 11 11 11 10 9 9 7
LIABILITIES
Total Liabilities 15 11 11 11 10 9 9 7
Current Liabilities 5 0 0 0 0 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 6 7 7 7 7 7 7 7
Share Capital 7 7 7 7 7 7 7 7
Reserves & Surplus -1 -1 0 0 0 0 0 0

BOSTONBIO Cash Flow Statement — Operating, Investing & Financing

BOSTON BIO SYSTEMS LTD. operating cash flow ₹-5 Cr, investing ₹0 Cr, financing ₹5 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2018 March 2017 March 2016 March 2015
Operating Activities -5 0 0 0 0 0 0 1
Investing Activities 0 0 0 0 0 0 0 -1
Financing Activities 5 0 0 0 0 0 0 0
Net Cash Flow 0 0 0 0 0 0 0 0